Literature DB >> 14622102

"Passive stabilization" of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat.

Brian P Bergstrom1, Paul A Garris.   

Abstract

Symptoms of Parkinson's disease do not present until the degeneration of nigrostriatal dopaminergic neurons is nearly complete. Maintenance of dopaminergic tone governing striatal efferents is postulated to preserve motor control during the presymptomatic phase, but the neuroadaptation responsible for normalization is not completely understood. In particular, the prevailing view that surviving dopaminergic neurons compensate by up-regulating release has been difficult to demonstrate directly. Here we investigate dopaminergic neurotransmission in the hemiparkinsonian rat using fast-scan cyclic voltammetry at carbon-fiber microelectrodes. Electrical stimulation was used to elicit extracellular dopamine levels mimicking the steady-state dynamics of tonic dopaminergic signaling. In agreement with microdialysis studies, evoked steady-state dopamine levels remained constant over the entire lesion spectrum (0 to approximately 85%) observed during the presymptomatic stage. Kinetic analysis of the voltammetric recordings demonstrated that evoked dopamine concentrations were normalized without plasticity of dopamine release and uptake, suggesting that the primary mechanisms controlling ambient levels of extracellular dopamine were not actively altered. In the present study, we formalize this neuroadaptation as "passive stabilization" . We further propose that passive stabilization is mediated by the simple physical principles of diffusion and steady state, is predicated on extrasynaptic transmission, and forms the basis for a new compensation model of preclinical parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622102     DOI: 10.1046/j.1471-4159.2003.02104.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  36 in total

1.  Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates.

Authors:  Xiomara A Perez; Neeraja Parameswaran; Luping Z Huang; Kathryn T O'Leary; Maryka Quik
Journal:  J Neurochem       Date:  2008-02-01       Impact factor: 5.372

Review 2.  Phasic dopamine release in appetitive behaviors and drug addiction.

Authors:  Matthew J Wanat; Ingo Willuhn; Jeremy J Clark; Paul E M Phillips
Journal:  Curr Drug Abuse Rev       Date:  2009-05

3.  Computational models of reinforcement learning: the role of dopamine as a reward signal.

Authors:  R D Samson; M J Frank; Jean-Marc Fellous
Journal:  Cogn Neurodyn       Date:  2010-03-21       Impact factor: 5.082

4.  Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson's Disease.

Authors:  Jonathan W McKinley; Ziqing Shi; Ivana Kawikova; Matthew Hur; Ian J Bamford; Suma Priya Sudarsana Devi; Annie Vahedipour; Martin Darvas; Nigel S Bamford
Journal:  Neuron       Date:  2019-07-16       Impact factor: 17.173

5.  Disruption of subcellular Arc/Arg 3.1 mRNA expression in striatal efferent neurons following partial monoamine loss induced by methamphetamine.

Authors:  Melissa L Barker-Haliski; Katharina Oldenburger; Kristen A Keefe
Journal:  J Neurochem       Date:  2012-10-10       Impact factor: 5.372

6.  Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment.

Authors:  Elaine Del-Bel; Fernando Eduardo Padovan-Neto; Raphael Escorsim Szawka; Célia Aparecida da-Silva; Rita Raisman-Vozari; Janete Anselmo-Franci; Angélica Caroline Romano-Dutra; Francisco Silveira Guimaraes
Journal:  Neurotox Res       Date:  2013-06-27       Impact factor: 3.911

7.  Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum.

Authors:  John D Robinson; Christopher D Howard; Elissa D Pastuzyn; Diane L Byers; Kristen A Keefe; Paul A Garris
Journal:  Neurotox Res       Date:  2014-02-22       Impact factor: 3.911

Review 8.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

9.  Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation.

Authors:  Christopher D Howard; Elissa D Pastuzyn; Melissa L Barker-Haliski; Paul A Garris; Kristen A Keefe
Journal:  J Neurochem       Date:  2013-04-01       Impact factor: 5.372

10.  Homeostatic mechanisms in dopamine synthesis and release: a mathematical model.

Authors:  Janet A Best; H Frederik Nijhout; Michael C Reed
Journal:  Theor Biol Med Model       Date:  2009-09-10       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.